Why SciSparc Ltd Stock Is Blasting Higher
Why SciSparc Ltd Stock Is Blasting Higher
SciSparc Ltd. (NASDAQ:SPRC) shares are trading higher Friday after the company announced it has launched a clinical trial of its combination of cannabidiol (CBD) and SciSparc's proprietary Palmitoylethanolamide, to treat the symptoms of autism spectrum disorder (ASD).
ScisParc Ltd.（納斯達克股票代碼：SPRC）週五股價走高，此前該公司宣佈已啓動一項針對大麻二酚（CBD）和ScisParc專有的棕櫚酰乙醇酰胺組合物的臨床試驗，以治療自閉症譜系障礙（ASD）的症狀。
The Details:
細節：
SciSparc said that the trial will enroll 60 participants between the ages of 5-18 years old and will measure how SCI-210 compares to standard CBD treatment in managing ASD symptoms.
ScisPARC表示，該試驗將招收60名年齡在5-18歲之間的參與者，並將衡量 SCI-210 與標準CBD治療在控制泛自閉症症狀方面的比較。
Oz Adler, SciSparc's CEO stated, "Our pioneering treatment aims to reduce and alleviate the symptoms of autism along with reducing the side effects that are common when taking cannabis-based treatments, such as CBD."
SciParc首席執行官奧茲·阿德勒表示：“我們的開創性療法旨在減少和緩解自閉症的症狀，同時減少服用基於大麻的療法（例如CBD）時常見的副作用。”
On Wednesday, SciSparc announced the signing of a non-binding letter of intent to merge with a leading vehicle importer company in Israel.
週三，SciParc宣佈簽署一份不具約束力的意向書，與以色列一家領先的汽車進口公司合併。
Shares of SPRC are up on heavy trading volume Friday. According to data from Benzinga Pro, more than 12.4 million shares have already been traded in the session, compared to the stock's 100-day average of 1.615 million shares.
週五，由於交易量大，SPRC的股價上漲。根據Benzinga Pro的數據，該交易日已經交易了超過1,240萬股，而該股的100天平均交易量爲161.5萬股。
Related News: What's Going On With Rivian Automotive Stock?
相關新聞：Rivian Automotive 股票怎麼了？
SPRC Price Action: According to Benzinga Pro, SciSparc shares are up by 53% at $11.35 at the time of publication.
SPRC價格走勢：根據Benzinga Pro的數據，截至發佈時，SciPARC的股價上漲了53％，至11.35美元。
Image: Bob G from Pixabay
圖片：來自 Pixabay 的 Bob G
譯文內容由第三人軟體翻譯。